Lexaria Bioscience Corp. (LEXX)
NASDAQ·Healthcare·Biotechnology
$0.89
-6.33%
Mkt Cap $14.10M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
Implied Upside
+68.5%
Consensus $1.50 vs current $0.89
NASDAQ·Healthcare·Biotechnology
$0.89
-6.33%
Mkt Cap $14.10M
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
+68.5%
Consensus $1.50 vs current $0.89